Infection prevention and control strategies in the era of limited resources and quality improvement: A perspective paper

Australian Critical Care

Volumn 26, Issue 4, 2013, Pages 154-157

  Vandijck, Dominique ^a,b   Cleemput, Irina ^b,c   Hellings, Johan ^b,d   Vogelaers, Dirk ^a,e  

^a GHENT UNIVERSITY   (Belgium)

^b HASSELT UNIVERSITY   (Belgium)

^c BELGIAN HEALTH CARE KNOWLEDGE CENTRE KCE   (Belgium)

^d ICURO   (Belgium)

^e GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Health economics; Healthcare associated infection; Infection prevention and control; Patient safety; Quality improvement; Resources

Indexed keywords

CROSS INFECTION; ECONOMICS; EVIDENCE BASED MEDICINE; HEALTH CARE PLANNING; HUMAN; INFECTION CONTROL; INTENSIVE CARE; INTENSIVE CARE UNIT; ORGANIZATION AND MANAGEMENT; PATIENT SAFETY; PROCEDURES; TOTAL QUALITY MANAGEMENT;

CRITICAL CARE; CROSS INFECTION; EVIDENCE-BASED MEDICINE; HEALTH RESOURCES; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS; PATIENT SAFETY; QUALITY IMPROVEMENT;

EID: 84888353999     PISSN: 10367314     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aucc.2013.07.005     Document Type: Article

References (51)

1. Vandijck D., Decruyenaere J.M., Blot S.I. The value of sepsis definitions in daily ICU-practice. Acta Clinica Belgica 2006, 61(5):220-226.
2. Reynvoet E., Vandijck D.M., Blot S.I., Dhondt A.W., De Waele J.J., Claus S., et al. Epidemiology of infection in critically ill patients with acute renal failure. Critical Care Medicine 2009, 37(7):2203-2209.
3. Wenzel R.P. The Lowbury Lecture. The economics of nosocomial infections. Journal of Hospital Infection 1995, 31(2):79-87.
4. Klevens R.M., Edwards J.R., Richards C.L., Horan T.C., Gaynes R.P., Pollock D.A., et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Reports 2007, 122(2):160-166.
5. Liu G.G., Guo J.J., Smith S.R. Economic costs to business of the HIV/AIDS epidemic. Pharmacoeconomics 2004, 22(18):1181-1194.
6. Stone P.W., Hedblom E.C., Murphy D.M., Miller S.B. The economic impact of infection control: making the business case for increased infection control resources. American Journal of Infection Control 2005, 33(9):542-547.
7. Burke J.P. Infection control - a problem for patient safety. New England Journal of Medicine 2003, 348(7):651-656.
8. Vandijck D.M., Blot S.I., Vogelaers D.P. Implementation of an evidence-based sepsis program in the intensive care unit: evident or not?. Critical Care (London, England) 2009, 13(5):193.
9. Plowman R., Graves N., Griffin M.A., Roberts J.A., Swan A.V., Cookson B., et al. The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. Journal of Hospital Infection 2001, 47(3):198-209.
10. Blot S., Cankurtaran M., Petrovic M., Vandijck D., Lizy C., Decruyenaere J., et al. Epidemiology and outcome of nosocomial bloodstream infection in elderly critically ill patients: a comparison between middle-aged, old, and very old patients. Critical Care Medicine 2009, 37(5):1634-1641.
11. Oeyen S.G., Vandijck D.M., Benoit D.D., Annemans L., Decruyenaere J.M. Quality of life after intensive care: a systematic review of the literature. Critical Care Medicine 2010, 38(12):2386-2400.
12. Stelfox H.T., Bates D.W., Redelmeier D.A. Safety of patients isolated for infection control. JAMA 2003, 290(14):1899-1905.
13. Vandijck D.M., Blot S.I., Decruyenaere J.M., Vanholder R.C., De Waele J.J., Lameire N.H., et al. Costs and length of stay associated with antimicrobial resistance in acute kidney injury patients with bloodstream infection. Acta Clinica Belgica 2008, 63(1):31-38.
14. Gardner G. The human dimension of nosocomial wound infection: a study in liminality. Nursing Inquiry 1998, 5(4):212-219.
15. Stone P.W., Braccia D., Larson E. Systematic review of economic analyses of health care-associated infections. American Journal of Infection Control 2005, 33(9):501-509.
16. Vandijck D.M., Blot S.I., Labeau S.O., Buyle F.M., Depaemelaere M., Vandewoude K.H., et al. Candidemia in critically ill patients: an analysis of daily antifungal therapy related costs. Journal de Mycologie Médicale 2008, 18:96-99.
17. Vandijck D.M., Depaemelaere M., Labeau S.O., Depuydt P.O., Annemans L., Buyle F.M., et al. Daily cost of antimicrobial therapy in patients with Intensive Care Unit-acquired, laboratory-confirmed bloodstream infection. International Journal of Antimicrobial Agents 2008, 31(2):161-165.
18. Depuydt P.O., Vandijck D.M., Bekaert M.A., Decruyenaere J.M., Blot S.I., Vogelaers D.P., et al. Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia. Critical Care (London, England) 2008, 12(6):R142.
19. Hugonnet S., Eggimann P., Borst F., Maricot P., Chevrolet J.C., Pittet D. Impact of ventilator-associated pneumonia on resource utilization and patient outcome. Infection Control and Hospital Epidemiology 2004, 25(12):1090-1096.
20. Karchmer T.B., Durbin L.J., Simonton B.M., Farr B.M. Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus. Journal of Hospital Infection 2002, 51(2):126-132.
21. Zingg W., Colombo C., Jucker T., Bossart W., Ruef C. Impact of an outbreak of norovirus infection on hospital resources. Infection Control and Hospital Epidemiology 2005, 26(3):263-267.
22. Van Den Bos J., Rustagi K., Gray T., Halford M., Ziemkiewicz E., Shreve J. The $17.1 billion problem: the annual cost of measurable medical errors. Health Affairs 2011, 30(4):596-603.
23. CDC Hospital infections cost U.S. billions of dollars annually 2000, 1-2. CDC Media Relations.
24. Wise M.E., Scott R.D., Baggs J.M., Edwards J.R., Ellingson K.D., Fridkin S.K., et al. National estimates of central line-associated bloodstream infections in critical care patients. Infection Control and Hospital Epidemiology 2013, 34(6):547-554.
25. Kaier K. Economic implications of the dynamic relationship between antibiotic use and hospital-acquired infections. Value in Health 2012, 15(1):87-93.
26. Kaier K., Moog S. Economic consequences of the demography of MRSA patients and the impact of broad-spectrum antimicrobials. Applied Health Economics and Health Policy 2012, 10(4):227-234.
27. Garcia R., Barnard B., Kennedy V. The fifth evolutionary era in infection control: interventional epidemiology. American Journal of Infection Control 2000, 28(1):30-43.
28. Jackson M., Massanari R.M. Reengineering and infection control programs: commentary and a case study. American Journal of Infection Control 2000, 28(1):44-50.
29. Rose R.C. Infection control to quality improvement: the right time, the right place, the work to be done. Clinical Performance and Quality Health Care 1997, 5(1):16-19.
30. Haley R.W., Culver D.H., White J.W., Morgan W.M., Emori T.G., Munn V.P., et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. American Journal of Epidemiology 1985, 121(2):182-205.
31. Jarvis W.R. Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost, and prevention. Infection Control and Hospital Epidemiology 1996, 17(8):552-557.
32. Vandijck D., Annemans L. Belgian healthcare: overview of the health system and financing. ICU Management 2010, 9:37-38.
33. Perencevich E.N., Stone P.W., Wright S.B., Carmeli Y., Fisman D.N., Cosgrove S.E. Raising standards while watching the bottom line: making a business case for infection control. Infection Control and Hospital Epidemiology 2007, 28(10):1121-1133.
34. O'Boyle C., Jackson M., Henly S.J. Staffing requirements for infection control programs in US health care facilities: Delphi project. American Journal of Infection Control 2002, 30(6):321-333.
35. Jarvis W.R. The state of the science of health care epidemiology, infection control, and patient safety, 2004. American Journal of Infection Control 2004, 32(8):496-503.
36. Dendale P., De Keulenaer G., Troisfontaines P., Weytjens C., Mullens W., Elegeert I., et al. Effect of a telemonitoring-facilitated collaboration between general practitioner and heart failure clinic on mortality and rehospitalization rates in severe heart failure: the TEMA-HF 1 (TElemonitoring in the MAnagement of Heart Failure) study. European Journal of Heart Failure 2012, 14(3):333-340.
37. McLean S., Nurmatov U., Liu J.L., Pagliari C., Car J., Sheikh A. Telehealthcare for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2011, (7). CD007718 (Online).
38. Soule B.M., Huskins W.C. A global perspective on the past, present, and future of nosocomial infection prevention and control. American Journal of Infection Control 1997, 25(4):289-293.
39. Goldrick B.A. The practice of infection control and applied epidemiology: a historical perspective. American Journal of Infection Control 2005, 33(9):493-500.
40. Vandijck D., Blot S. High acuity nurse: patient ratio - is it cost-effective?. Controversies in intensive care medicine 2008, 195-207. MWV Medizinisch Wissenschaftliche Verlagsgesellschaft, Berlin. R. Kuhlen, R. Moreno, M. Ranieri, A. Rhodes (Eds.).
41. Zoutman D.E., Ford B.D. The relationship between hospital infection surveillance and control activities and antibiotic-resistant pathogen rates. American Journal of Infection Control 2005, 33(1):1-5.
42. Depuydt P., Benoit D., Vogelaers D., Decruyenaere J., Vandijck D., Claeys G., et al. Systematic surveillance cultures as a tool to predict involvement of multidrug antibiotic resistant bacteria in ventilator-associated pneumonia. Intensive Care Medicine 2008, 34(4):675-682.
43. Pritchard V. Joint Commission standards for long-term care infection control: putting together the process element. Joint Commission on Accreditation of Healthcare Organizations. American Journal of Infection Control 1999, 27(1):27-34.
44. Weinstein R.A., Siegel J.D., Brennan P.J. Infection-control report cards-securing patient safety. New England Journal of Medicine 2005, 353(3):225-227.
45. Vlayen A., Verelst S., Bekkering G.E., Schrooten W., Hellings J., Claes N. Incidence and preventability of adverse events requiring intensive care admission: a systematic review. Journal of Evaluation in Clinical Practice 2012, 18(2):485-497.
46. Skolnick A.A. JCAHO, NCQA, and AMAP, establish council to coordinate health care performance measurement. Joint Commission on Accreditation of Healthcare Organizations, National Committee for Quality Assurance, American Medical Accreditation Program. JAMA 1998, 279(22):1769-1770.
47. CDC Monitoring hospital-acquired infections to promote patient safety-United States, 1990-1999. MMWR - Morbidity and Mortality Weekly Report 2000, 49(8):149-153.
48. Berenholtz S.M., Pronovost P.J., Lipsett P.A., Hobson D., Earsing K., Farley J.E., et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Critical Care Medicine 2004, 32(10):2014-2020.
49. (PHC4) PHCCCC Hospital-acquired infections in Pennsylvania 2009, http://www.phc4.org/reports/hai/07/default.htm.
50. Scott R.D. The direct medical costs of healthcare-associated infections in U.S. hospitals and the benefits of prevention 2009, http://www.cdc.gov/ncidod/dhqp/pdf/Scott_CostPaper.pdf.
51. Hellings J., Schrooten W., Klazinga N.S., Vleugels A. Improving patient safety culture. International Journal of Health Care Quality Assurance 2010, 23(5):489-506.